CXCR4 and plasma cell myeloma: Here, we provide the first evaluation of in vivo CXCR4 imaging in a series of patients with a particular cancer of the lymphoid system, multiple myeloma, using the CXCR4-specific PET tracer Pentixafor in comparison with the clinically established tracer FDG.